Introduction to DOK2 and its potential role in cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Cancer is a complex disease with multifactorial origins.
• Downstream of tyrosine kinase 2 (DOK2) is recognized as a tumor suppressor gene.
• DOK2 belongs to the downstream protein DOK family of tyrosine kinases.

Purpose of the Study:

• To review the mechanisms by which DOK2 influences cancer development.
• To identify DOK2 as a potential therapeutic target for cancer treatment and prevention.
• To analyze DOK2's role across various cancer types, including lung, liver, breast, and intestinal cancers.

Main Methods:

• Comprehensive literature search of original research indexed in PubMed and other scientific databases.
• Systematic review and analysis of studies focusing on DOK2's function in tumorigenesis.
• Examination of signaling pathways implicated in DOK2's mechanism of action.

Main Results:

• DOK2 exhibits tumor-suppressive functions in multiple cancer types.
• DOK2's activity is linked to the Ras/MPAK/ERK and PI3K/AKT/mTOR signaling pathways.
• Evidence suggests DOK2's involvement in lung, intestinal, liver, and breast cancers.

Conclusions:

• DOK2 represents a promising target for developing novel cancer therapies.
• Understanding DOK2's molecular mechanisms can lead to more effective cancer prevention and treatment strategies.
• Further research into DOK2 signaling pathways may uncover new therapeutic avenues.